Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Quetiapine-induced insulin resistance after switching from blonanserin despite a loss in both bodyweight and waist circumference.

Suzuki Y, Sugai T, Fukui N, Watanabe J, Ono S, Tsuneyama N, Saito M, Someya T.

Psychiatry Clin Neurosci. 2012 Oct;66(6):534-5. doi: 10.1111/j.1440-1819.2012.02388.x. No abstract available.

2.

Improvement in quetiapine-induced hypoglycemia following a switch to blonanserin.

Suzuki Y, Tsuneyama N, Sugai T, Fukui N, Watanabe J, Ono S, Saito M, Someya T.

Psychiatry Clin Neurosci. 2012 Jun;66(4):370-1. doi: 10.1111/j.1440-1819.2012.02338.x. No abstract available.

3.

Efficacy and tolerability of Blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trial.

Yang J, Bahk WM, Cho HS, Jeon YW, Jon DI, Jung HY, Kim CH, Kim HC, Kim YK, Kim YH, Kwon JS, Lee SY, Lee SH, Yi JS, Yoon BH, Kim SH.

Clin Neuropharmacol. 2010 Jul;33(4):169-75. doi: 10.1097/WNF.0b013e3181dcda50.

PMID:
20661022
4.

Weight loss and anorexia with quetiapine.

Khawaja IS, Azeem MW, Ebrahim A.

Psychiatr Serv. 2005 Apr;56(4):490. No abstract available.

PMID:
15812105
5.

[Blonanserin in the treatment of schizophrenia].

Tenjin T, Miyamoto S.

Nihon Rinsho. 2013 Apr;71(4):660-5. Review. Japanese.

PMID:
23678596
6.

One-year follow-up study of psychotic patients treated with blonanserin: a case series.

Takahashi S, Suzuki M, Uchiyama M.

Asia Pac Psychiatry. 2013 Sep;5(3):164-7. doi: 10.1111/j.1758-5872.2012.00232.x. Epub 2012 Aug 31.

PMID:
23857800
7.

Blonanserin, a novel antipsychotic, is suitable for treating schizophrenia associated with hyperprolactinemia: a case series.

Kawabe K, Horiuchi F, Ueno S.

Clin Neuropharmacol. 2013 Nov-Dec;36(6):239-41. doi: 10.1097/WNF.0000000000000006.

PMID:
24201238
8.

Blonanserin. AD 5423.

[No authors listed]

Drugs R D. 2002;3(6):405-6. No abstract available.

PMID:
12516946
9.

Switching from quetiapine to ziprasidone: a sixteen-week, open-label, multicenter study evaluating the effectiveness and safety of ziprasidone in outpatient subjects with schizophrenia or schizoaffective disorder.

Karayal ON, Glue P, Bachinsky M, Stewart M, Chappell P, Kolluri S, Cavus I.

J Psychiatr Pract. 2011 Mar;17(2):100-9. doi: 10.1097/01.pra.0000396061.05269.c8.

PMID:
21430488
10.

Blonanserin: a review of its use in the management of schizophrenia.

Deeks ED, Keating GM.

CNS Drugs. 2010 Jan;24(1):65-84. doi: 10.2165/11202620-000000000-00000. Review.

PMID:
20030420
11.

Adjunctive treatment with low-dosage aripiprazole for blonanserin-induced hyperprolactinemia in a female patient with schizophrenia.

Ishitobi M, Kosaka H, Shukunami K, Murata T, Wada Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Oct 1;34(7):1361-2. doi: 10.1016/j.pnpbp.2010.07.011. Epub 2010 Jul 18. No abstract available.

PMID:
20647025
12.

A prospective study of glucose homeostasis in quetiapine-treated schizophrenic patients by using the intravenous glucose tolerance test.

Chen CH, Lin TY, Chen TT, Chen VC, Lin NC, Shao WC, Lu ML.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):965-9. doi: 10.1016/j.pnpbp.2011.01.015. Epub 2011 Feb 1.

PMID:
21291941
13.

Three cases of schizophrenia showing improvement after switching to blonanserin.

Kurotaki N, Nobata H, Nonaka S, Nishihara K, Ozawa H.

Psychiatry Clin Neurosci. 2011 Jun;65(4):396-7. doi: 10.1111/j.1440-1819.2011.02223.x. No abstract available.

14.

Treatment-emergent tardive dyskinesia with quetiapine in mood disorders.

Sharma V.

J Clin Psychopharmacol. 2003 Aug;23(4):415-7. No abstract available.

PMID:
12920421
15.

Reversal of antipsychotic-induced weight gain during quetiapine treatment.

Koponen H, Larmo I.

Int Clin Psychopharmacol. 2003 Nov;18(6):355-6.

PMID:
14571156
16.

Quetiapine and elevated creatine phosphokinase (CK).

Plesnicar BK, Lasic JK, Plesnicar A.

Pharmacopsychiatry. 2007 Sep;40(5):203-4. No abstract available.

PMID:
17874354
17.

Sexual disinhibition in schizophrenia possibly induced by risperidone and quetiapine.

Lam MH, Fong SY, Wing YK.

Psychiatry Clin Neurosci. 2007 Jun;61(3):333. No abstract available.

19.

Increased libido associated with quetiapine.

Menon A, Williams RH, Watson S.

J Psychopharmacol. 2006 Jan;20(1):125-7.

PMID:
16354735
20.

Quetiapine: a well-tolerated and effective atypical antipsychotic.

Hellewell JS.

Hosp Med. 2002 Oct;63(10):600-3. Review.

PMID:
12422494

Supplemental Content

Support Center